News stories about Cognex (NASDAQ:CGNX) have been trending somewhat positive on Friday, according to Accern. Accern identifies positive and negative news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cognex earned a news sentiment score of 0.15 on Accern’s scale. Accern also gave headlines about the scientific and technical instruments company an impact score of 46.8548195551773 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s rankings:
- Cognex to Present at Needham Growth Conference (finance.yahoo.com)
- Cognex Corporation (NASDAQ:CGNX) – Historical Performances are Key to Consider – Nasdaq Journal (press release) (nasdaqjournal.com)
- Cognex (CGNX) Rating Lowered to Sell at Zacks Investment Research (americanbankingnews.com)
- Cognex Co. to Post FY2017 Earnings of $1.39 Per Share, Northcoast Research Forecasts (CGNX) (americanbankingnews.com)
- Cognex Corporation (NasdaqGS:CGNX) EV Value Sitting at 10307103 – Clawson News (clawsonnews.com)
Shares of Cognex (CGNX) traded up $0.79 during midday trading on Friday, hitting $66.38. The stock had a trading volume of 1,381,800 shares, compared to its average volume of 2,360,000. The company has a market capitalization of $11,500.00, a price-to-earnings ratio of 48.81 and a beta of 1.50. Cognex has a one year low of $31.50 and a one year high of $72.99.
Several analysts have issued reports on the company. Zacks Investment Research lowered Cognex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. JPMorgan Chase & Co. lowered Cognex from a “neutral” rating to an “underweight” rating and set a $62.50 price objective on the stock. in a research note on Wednesday, November 8th. ValuEngine lowered Cognex from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. BidaskClub lowered Cognex from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Finally, Canaccord Genuity upped their price objective on Cognex from $47.50 to $60.00 and gave the company a “hold” rating in a research note on Tuesday, October 31st. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $60.17.
In related news, Director Jeffrey Benjamin Miller sold 7,500 shares of the stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $124.23, for a total transaction of $931,725.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Robert Willett sold 100,000 shares of the stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $127.19, for a total value of $12,719,000.00. Following the sale, the chief executive officer now directly owns 100,000 shares in the company, valued at approximately $12,719,000. The disclosure for this sale can be found here. In the last quarter, insiders have sold 143,750 shares of company stock worth $18,540,975. 5.60% of the stock is owned by corporate insiders.
Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.